CIHR Dementia Research Strategy – National Component

Canadian Consortium on Neurodegeneration in Aging (CCNA)

The Canadian Consortium on Neurodegeneration in Aging (CCNA) is the premier research hub for all aspects of research involving neurodegenerative diseases that affect cognition in aging – including Alzheimer's disease. Initially funded in 2014, the CCNA was renewed into its second phase in April 2019. The CCNA is funded by CIHR and many partners (see below). Dr. Howard Chertkow leads CCNA and is supported by an extended team of researchers across Canada. Learn more

New Directions in Dementia Research

The New Directions in Dementia Research suite of programs targeted specific research areas with important unmet needs. Following the launch of the CCNA, and in consultations with relevant stakeholders and partners, several areas of further investment were identified. These investments were linked to a unique availability of resources at CIHR and were linked or synergized in some fashion with the work of the CCNA in order to ensure that research investments in these areas are optimized for Canada. Learn more

Date modified: